Table 1.
Variables | All patients | circ-GALNT16 | P value | |
---|---|---|---|---|
Low | High | |||
All Cases | 100 | 50 | 50 | |
Age (years) | ||||
<60 | 35 | 16 | 19 | 0.53 |
≥60 | 65 | 34 | 31 | |
Gender | ||||
Female | 41 | 18 | 23 | 0.31 |
Male | 59 | 32 | 27 | |
Tumor size (cm) | ||||
<5 | 55 | 19 | 36 | 0.001 |
≥5 | 45 | 31 | 14 | |
Tumor stage | ||||
Stage I+II | 59 | 22 | 37 | 0.002 |
Stage III+IV | 41 | 28 | 13 | |
Lymph node metastasis | ||||
No | 61 | 23 | 38 | 0.002 |
Yes | 39 | 27 | 12 | |
Distant metastasis | ||||
No | 93 | 47 | 46 | >0.99 |
Yes | 7 | 3 | 4 | |
CEA (ng/ml) | ||||
<4.70 | 46 | 25 | 21 | 0.42 |
≥4.70 | 54 | 25 | 29 |
NOTE: CEA carcinoembryonic antigen
All data are presented as the means ± SD of three independent experiments. P ≤ 0.05 was considered significant. The bold type represents P values smaller than 0.05